TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma
Background Microwave ablation (MWA) is a widely adopted treatment technique for hepatocellular carcinoma (HCC). However, MWA alone is of limited use and has a high recurrence rate. Transforming growth factor-β1 (TGF-β1) is recognized as a potential therapeutic target for HCC patients. Therefore, thi...
Saved in:
Main Authors: | Shufang Xiang, Juan Li, Mei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | International Journal of Hyperthermia |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/02656736.2024.2359496 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
by: Olivia Kola, et al.
Published: (2025-01-01) -
The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
by: Wenhui Wang, et al.
Published: (2025-01-01) -
Research Progress on Tumor Treatment Strategies Targeting TGF-β
by: Jian ZHANG, et al.
Published: (2025-01-01) -
TGF-β signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance
by: Junwei Ge, et al.
Published: (2025-01-01) -
Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review
by: Gui-Lin Xie, et al.
Published: (2025-01-01)